STOCK TITAN

Nephros to Present at the Benchmark Company 10th Annual One-on-One Discovery Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

SOUTH ORANGE, NJ, Nov. 23, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nephros, Inc.(Nasdaq: NEPH), a leading water technology company providing innovative filtration and pathogen detection solutions to healthcare and commercial markets, today announced that Andy Astor, Chief Executive Officer of Nephros will be attending the Benchmark Company 10th Annual One-on-One Discovery Conference. The conference is taking place virtually on December 2, 2021, in a one-on-one and small group meeting format. The invitation-only event is for institutional clients of the Benchmark Company. For additional details, please contact Director of Corporate Access, Vince Curatola, at 414-203-5556.

About the Benchmark Company

The Benchmark Company is an institutionally focused, research driven, sales, trading & investment banking firm. Over the last 35 years, we have been steadfastly dedicated to our mission of fostering the long-term success of our clients. Our goal is to provide significant value by leveraging the resources that exist across our broad platform. This approach has enabled us to offer unbiased guidance and exceptional transaction execution to a broad range of clients over a variety of market conditions. For more information, please visit www.benchmarkcompany.com.

About Nephros

Nephros, Inc. is a company committed to improving the human relationship with water through leading, accessible technology. We provide innovative filtration and pathogen detection as part of an integrated approach to water safety that combines science, solutions, and support services. Nephros products serve the needs of customers within the healthcare and commercial markets, offering both proactive and emergency responses for water management. 

For more information about Nephros, please visit www.nephros.com.

Investor Relations Contacts:
Kirin Smith, President
PCG Advisory, Inc.
(646) 823-8656
ksmith@pcgadvisory.com

Andy Astor, CEO
Nephros, Inc.
(201) 345-0824
andy@nephros.com


Nephros Inc.

NASDAQ:NEPH

NEPH Rankings

NEPH Latest News

NEPH Stock Data

23.20M
5.62M
11.96%
40.29%
0.02%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
SOUTH ORANGE

About NEPH

nephros is a commercial stage medical device company that develops and sells high performance liquid purification filters. nephros filters capture contaminants as small as 5 nanometers in size; they minimize exposure to a wide variety of bacteria, viruses, fungi, parasites, and endotoxins. nephros filters use a proprietary hollow fiber technology; the hollow fiber design enables the filters to optimize the three elements critical to filter performance: • filtration – as low as 5 nanometers • flow rate – minimal disruption • filter life – up to 12 months nephros was founded in 1997, by healthcare professionals affiliated with columbia university medical center, initially to address the needs of chronic renal failure patients. the company has developed an alternative to current hemodialysis therapy known as mid-dilution hemodiafiltration (mid-hdf). nephros’ proprietary blood purification technologies enable mid-hdf to be offered to chronic renal failure patients. nephros mid-dilution fil